References

1. Lamont R, Joergensen SS, Vinter C. Re: Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early- onset Group B streptococcal disease: A systematic review and meta-analysis. (First comment letter. Reference to be added).
2. Hasperhoven GF, Al‐Nasiry S, Bekker V, Villamor E, Kramer BW. Universal screening versus risk‐based protocols for antibiotic prophylaxis during childbirth to prevent early‐onset Group B streptococcal disease: a systematic review and meta‐analysis. Vol. 127, BJOG: An International Journal of Obstetrics & Gynaecology. 2020;127(6). doi: 10.1111/1471-0528
3. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues. Vol. 127, Pediatrics. 2011 May 1;127(5):817–26. doi: 10.1542/peds.2010-2217
4. Kenchington AL, Lamont RF. Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease. Vol. 16, Expert Review of Vaccines. Taylor and Francis Ltd; 2017. p. 15–25. doi: 10.1080/14760584.2016.1209113
5. Walker K, Gray J, Petrou S, Ayers S, Ogollah R, Ojha S, et al. The clinical and cost-effectiveness of testing for Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations (GBS3). Vol. 126, BJOG : an international journal of obstetrics and gynaecology. 2019;126(S1).